1. Over three decades of experience in the surgical products business, supported by a broad and diversified product portfolio.
2. Well-positioned to capture opportunities in the growing addressable market for healthcare and surgical products.
3. Well-equipped, strategically located manufacturing facility with advanced process capabilities that drive operational efficiency.
4. Established domestic and international distribution network enabling broad market access and wide geographic reach.
5. Experienced Promoters supported by a qualified management team.
6. Track record of strong operational and financial performance.
...
well as medical implantable devices including hydrocephalus shunts and orthopaedic implants, among others. For Fiscal 2025, our revenue from operations was 2,239.76 million, which was the highest among our peers in India (source: 1Lattice Report). Our Company was founded by Ghanshyam Das Agarwal in 1990 and has over three decades of experience in the surgical products business. We started our operations with the manufacturing of disposable surgical drapes and hydrocephalus shunt systems. Over the years, we have expanded our operations and diversified our product portfolio beyond disposable surgical drapes and dressings and hydrocephalus shunt systems to include other surgical and medical implantable devices and products such as bone grafting products, lumbar external drainage systems and cerebral catheter reservoirs. As part of our product portfolio, we manufacture several products that fall under stricter regulatory classifications (Class C and Class D) under the framework of the Central Drugs Standard Control Organization. These classes are subject to more stringent regulatory scrutiny, including clinical evaluation requirements and risk-based audits, as compared to Class A and Class B products (source: 1Lattice Report). Our ability to obtain and maintain such approvals reflects our regulatory capabilities and compliance standards. Read More
Posted on Jan 20th
Rudra Ecovation informs about press release
Posted on Jan 20th
Nitin Nabin takes over as BJP president
Posted on Jan 20th
Currency futures for January expiry trade weaker with 7.31% increase in OI
Posted on Jan 19th
Shadowfax Technologies coming with IPO to raise Rs 2004.24 crore
The issue size of G Surgiwear Ltd. IPO is ₹0.00 - 0.00 crore.
The G Surgiwear Ltd. IPO opens for subscription on and closes on .
The price range of G Surgiwear Ltd. IPO is ₹0.00 to ₹0.00.
The lot size of G Surgiwear Ltd. IPO is shares.
The registrar of G Surgiwear Ltd. IPO is Bigshare Services Pvt Ltd .
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.